Matters related to access to and pricing of plasma derived products and matters affecting the Orphan Drug Act and therapies for rare diseases.
2025 · 1st Quarter (Jan 1 - Mar 31)
PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Filed by WILLIAMS AND JENSEN, PLLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- WILLIAMS AND JENSEN, PLLC
- Filing UUID
- d33df293-41e8-426a-8571-e47cad0a3db1
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Matters affecting plasma donation and potential plasma shortages. Issues related to PAHPA.
Tax legislation affecting the Orphan Drug Tax Credit and the Research and Development Tax Credit.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.